These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19390222)

  • 1. Expression and activity of SGLT2 in diabetes induced by streptozotocin: relationship with the lipid environment.
    Albertoni Borghese MF; Majowicz MP; Ortiz MC; Passalacqua Mdel R; Sterin Speziale NB; Vidal NA
    Nephron Physiol; 2009; 112(3):p45-52. PubMed ID: 19390222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental type II diabetes and related models of impaired glucose metabolism differentially regulate glucose transporters at the proximal tubule brush border membrane.
    Chichger H; Cleasby ME; Srai SK; Unwin RJ; Debnam ES; Marks J
    Exp Physiol; 2016 Jun; 101(6):731-42. PubMed ID: 27164183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats.
    Osorio H; Bautista R; Rios A; Franco M; Arellano A; Vargas-Robles H; Romo E; Escalante B
    J Nephrol; 2010; 23(5):541-6. PubMed ID: 20349407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats.
    Osorio H; Coronel I; Arellano A; Franco M; Escalante B; Bautista R
    Diabetes Res Clin Pract; 2012 Aug; 97(2):276-82. PubMed ID: 22429686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity.
    Freitas HS; Anhê GF; Melo KF; Okamoto MM; Oliveira-Souza M; Bordin S; Machado UF
    Endocrinology; 2008 Feb; 149(2):717-24. PubMed ID: 17962340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of SGLT2 in the kidney of a P. gingivalis LPS-induced diabetic nephropathy mouse model.
    Kajiwara K; Sawa Y
    BMC Nephrol; 2021 Aug; 22(1):287. PubMed ID: 34425759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes.
    Solini A; Rossi C; Mazzanti CM; Proietti A; Koepsell H; Ferrannini E
    Diabetes Obes Metab; 2017 Sep; 19(9):1289-1294. PubMed ID: 28419670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sodium-glucose cotransporter activity and aquaporin-2 expression in rat kidney during chronic nitric oxide synthase inhibition.
    Albertoni Borghese MF; Majowicz MP; Ortiz MC; Delgado MF; Sterin Speziale NB; Vidal NA
    Nephron Physiol; 2007; 107(3):p77-86. PubMed ID: 17940347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats.
    Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
    J Pharm Pharmacol; 2014 Jul; 66(7):975-87. PubMed ID: 24533859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences.
    Sabolic I; Vrhovac I; Eror DB; Gerasimova M; Rose M; Breljak D; Ljubojevic M; Brzica H; Sebastiani A; Thal SC; Sauvant C; Kipp H; Vallon V; Koepsell H
    Am J Physiol Cell Physiol; 2012 Apr; 302(8):C1174-88. PubMed ID: 22262063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice.
    Tahara A; Takasu T; Yokono M; Imamura M; Kurosaki E
    Arch Pharm Res; 2016 Feb; 39(2):259-270. PubMed ID: 26450351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.
    Umino H; Hasegawa K; Minakuchi H; Muraoka H; Kawaguchi T; Kanda T; Tokuyama H; Wakino S; Itoh H
    Sci Rep; 2018 May; 8(1):6791. PubMed ID: 29717156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice.
    Nakatsu Y; Kokubo H; Bumdelger B; Yoshizumi M; Yamamotoya T; Matsunaga Y; Ueda K; Inoue Y; Inoue MK; Fujishiro M; Kushiyama A; Ono H; Sakoda H; Asano T
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin.
    Brady JA; Hallow KM
    J Clin Pharmacol; 2018 Mar; 58(3):377-385. PubMed ID: 29144539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.
    Li S; Wang N; Guo X; Li J; Zhang T; Ren G; Li D
    Biomed Pharmacother; 2018 Dec; 108():355-366. PubMed ID: 30227329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy?
    Fekete A; Rosta K; Wagner L; Prokai A; Degrell P; Ruzicska E; Vegh E; Toth M; Ronai K; Rusai K; Somogyi A; Tulassay T; Szabo AJ; Ver A
    J Physiol; 2008 Nov; 586(22):5337-48. PubMed ID: 18818245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Na
    Koepsell H
    Pharmacol Ther; 2017 Feb; 170():148-165. PubMed ID: 27773781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic regulation of the renal Na/H+ exchanger NHE3 in rats with STZ-induced diabetes mellitus.
    Klisic J; Nief V; Reyes L; Ambuhl PM
    Nephron Physiol; 2006; 102(2):p27-35. PubMed ID: 16244498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved glycemic control in mice lacking Sglt1 and Sglt2.
    Powell DR; DaCosta CM; Gay J; Ding ZM; Smith M; Greer J; Doree D; Jeter-Jones S; Mseeh F; Rodriguez LA; Harris A; Buhring L; Platt KA; Vogel P; Brommage R; Shadoan MK; Sands AT; Zambrowicz B
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E117-30. PubMed ID: 23149623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic disturbances and defects in insulin secretion in rats with streptozotocin-nicotinamide-induced diabetes.
    Szkudelski T; Zywert A; Szkudelska K
    Physiol Res; 2013; 62(6):663-70. PubMed ID: 23869889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.